Ranging from whole genome karyotyping to the measurement of transgene integration at a specified target site, our assays are designed to detect the intended and unintended outcomes on the structure of the genome from an editing process.

Our dGH™ platform detects structural variants throughout the genome in both an unbiased and targeted manner, potentially even at frequencies below one percent. With your editing system and specific data interests in hand, we advise on experimental cohort and design, and perform a genomic integrity analysis for your therapeutic program as a service.

You can rest assured that KromaTiD understands the importance of GLP and GMP services for maintaining high standards. Ask us about our GLP and GMP services to see how we can support your genomic integrity analysis needs.